Options Brief: Exelixis, Inc. (EXEL)

Shares of Exelixis, Inc. EXEL are higher on the session by 6.70%, trading at $11.79. Overall call volume is now running at 5.88x the daily average, with 59% of all calls traded being purchases on the offer. 1,724 contracts have traded on the session so far. Exelixis, Inc. is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases. The majority of its programs focus on discovery and development of small molecule drugs for cancer.